Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer.
about
Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesisInfluence of hypoxia and neoangiogenesis on the growth of pancreatic cancerCurrent targeted therapies in the treatment of advanced colorectal cancer: a reviewRamucirumab in metastatic colorectal cancer: evidence to date and place in therapyIncidence and management of ZIv-aflibercept related toxicities in colorectal cancerNeuropilins: expression and roles in the epitheliumKDR Mutation as a Novel Predictive Biomarker of Exceptional Response to Regorafenib in Metastatic Colorectal CancerNeuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesisHypoxia and VEGF mRNA expression in human tumorsEGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cellsMutant epidermal growth factor receptor enhances induction of vascular endothelial growth factor by hypoxia and insulin-like growth factor-1 via a PI3 kinase dependent pathwayPhase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic CancerDimethylarginine dimethylaminohydrolase I enhances tumour growth and angiogenesisUltrasound Molecular Imaging of Angiogenesis Using Vascular Endothelial Growth Factor-Conjugated Microbubbles.Optimization of Contrast-to-Tissue Ratio Through Pulse Windowing in Dual-Frequency "Acoustic Angiography" ImagingOn the relationship between microbubble fragmentation, deflation and broadband superharmonic signal production.Three-dimensional ultrasound molecular imaging of angiogenesis in colon cancer using a clinical matrix array ultrasound transducer.Opportunities and challenges for successful use of bevacizumab in pediatrics.Vascular endothelial growth factor as an anti-angiogenic target for cancer therapyPhase I and pharmacokinetic study of TSU-68, a novel multiple receptor tyrosine kinase inhibitor, by twice daily oral administration between meals in patients with advanced solid tumorsPhase I pharmacokinetic and pharmacodynamic study of cetuximab, irinotecan and sorafenib in advanced colorectal cancerRole of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer.VEGF targets the tumour cell.Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.DHX32 Promotes Angiogenesis in Colorectal Cancer Through Augmenting β-catenin Signaling to Induce Expression of VEGFADiscovery of a New Series of Naphthamides as Potent VEGFR-2 Kinase InhibitorsAssessment of vascular endothelial growth factor in formalin fixed, paraffin embedded colon cancer specimens by means of a well-based reverse phase protein arrayCorrelation between serum tryptase, mast cells positive to tryptase and microvascular density in colo-rectal cancer patients: possible biological-clinical significance.Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by FluorescenceThe RON tyrosine kinase receptor regulates vascular endothelial growth factor production in pancreatic cancer cells.The clinicopathological significance of tissue levels of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in gastric cancer.Expression of vascular endothelial growth factors A and C in human pancreatic cancer.Functional and structural characteristics of tumor angiogenesis in lung cancers overexpressing different VEGF isoforms assessed by DCE- and SSCE-MRI.Cell surface molecules and their prognostic values in assessing colorectal carcinomas.Vascular endothelial growth factor receptor-2 in breast cancer.Angiogenesis in epithelian ovarian cancer.Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomas.Quantum dots targeted to vascular endothelial growth factor receptor 2 as a contrast agent for the detection of colorectal cancer.A serum-stable branched dimeric anti-VEGF peptide blocks tumor growth via anti-angiogenic activityIn vitro and in vivo studies of a VEGF121/rGelonin chimeric fusion toxin targeting the neovasculature of solid tumors.
P2860
Q24321673-54A9AEA5-7F8E-4BFF-96D1-9D317BC01A92Q24801511-581EA151-57C2-4387-A654-AAFAB8ACF0E3Q26740067-64F17BC7-61B2-45B4-B4E8-7CD92CEF2FB1Q26745418-FD303A4B-DBE5-496F-BAA2-324927279EE2Q26830219-2179275D-48E9-49AC-B5C8-BC1736EF7558Q26998786-71CD8309-B82A-4EE3-A27E-B23382202784Q27853363-4BE2E6DC-64CB-4A30-9A68-59652092C1D7Q28263245-DCB503E3-1658-4E73-9989-CAB8428841C6Q28344471-07C0871C-DE7A-4F4E-AC07-3E769DB9D9E6Q28360903-4AA0F8F5-034C-44A6-860E-67DA0DAE1376Q28365260-D3976571-A717-4F19-B720-25E2169C7DE8Q28552089-0D795969-48AD-42A9-849C-A8FAD66842E2Q28578409-E2C78C0D-5207-4E0A-8D03-C3F944AB64BDQ30359568-4631760A-56DD-45DE-B1DA-87E09918852FQ30380572-A15D0437-F155-4D24-8497-D8D8B2621B53Q30382620-4082F7BA-D8E9-45F3-B021-68DE84782157Q30384642-974223AE-0B1D-42DB-97BA-DECC41C3606BQ30454883-624C262B-58D0-451E-B13A-891E813B0C51Q30455612-E569460A-8DC8-4D43-9A07-3F597F46C29DQ33391125-02E95F23-1E02-4A4A-8A62-F49302DB0300Q33401352-0B9148BC-553B-4C83-B1B0-4ABA186A128FQ33539996-57DD566D-D061-446D-B17E-F6C0FD98C107Q33573324-5451AB51-2102-4354-A2EB-000AB0B3F31AQ33577505-1FE0977A-AEA8-4D4A-8246-CB1AEE0E7F3DQ33603626-A769D048-23BE-4BC2-828E-9B343DB7F080Q33636113-B2B18DBB-3DBC-4356-A676-8AE818F311C5Q33688120-152F3CB8-A417-43AC-8B53-E28CF30193EAQ33734545-177E109D-965D-4742-8FA3-DC5E1483BF6EQ33759991-338DC724-7210-41E2-8A5B-2D73C45DD137Q33768073-4F8B3AF1-7132-4C5D-B84F-CB2163A4BA46Q33781573-269050AE-8E80-4270-BB39-5F1A43A7C9CDQ33788147-2968B9DC-BF1C-4A3C-88A0-59B52E53C75EQ33809311-EAC7FF0A-6B0A-480D-B544-18AE4F4AB6C1Q33818072-F0ED3D2E-CFBE-4399-9B33-4CAA152CAEBDQ33912620-577F4B82-A609-4E73-98EB-6CC1F6A4E023Q33919078-B982A3E5-8F0D-4BCC-BFB6-E81D464B9CDBQ33943812-70152CBB-6D56-4409-80E3-B44A4D804D21Q34011681-4BAF3A03-0F97-4863-A3A9-D2D903035BBAQ34029831-3D2E746A-81AA-46CF-9CCE-52EA436A72C3Q34030193-F4853D3B-A311-44D3-983D-E1F237D05B6D
P2860
Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Expression of vascular endothe ...... eration of human colon cancer.
@en
type
label
Expression of vascular endothe ...... eration of human colon cancer.
@en
prefLabel
Expression of vascular endothe ...... eration of human colon cancer.
@en
P2093
P1433
P1476
Expression of vascular endothe ...... eration of human colon cancer.
@en
P2093
P304
P407
P577
1995-09-01T00:00:00Z